The development of in vitro methods for the identification of skin sensitizers based upon analysis of Langerhans cell (LC) function has been constrained by the fact that these cells represent only a minority population in the skin that, once isolated, alter their phenotype spontaneously and rapidly.
Interleukin-1β converting enzyme in murine Langerhans cells and epidermal-derived dendritic cell lines
✍ Scribed by Kiyoshi Ariizumi; Toshiyuki Kitajima; Paul R. Bergstresser; Akira Takashima
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 582 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Interleukin (IL)
-lp plays an essential role in the induction of T cell-mediated immune responses in skin. Langerhans cells (LC), which constitutively express IL-lp mRNA, have been assumed to be the primary source of IL-lP in murine epidermis. The purpose of this study was to determine whether LC express mRNA for the IL-113 converting enzyme (ICE), a protease that is required for processing pro-IL-10 into an active form. Here, we report that both IL-lg and ICE mRNA are expressed by the Ia' population (i.e. LC) in murine epidermis. Moreover, murine epidermal-derived DC lines (XS series) also express both IL-1P and ICE mRNA, and they secrete relatively large amounts of IL-lp following lipopolysaccharide (LPS) stimulation. Finally. LPS-triggered IL-113 secretion by XS cells is blocked almost completely by the ICE inhibitor acetyl-Tyr-Val-Ala-Asp-CH20C(0)-[2,6-(CF,),]Ph. These results demonstrate that LC are the primary source of IL-113 within the epidermis, and suggest that the proinflammatory role of IL-113 may be regulated pharmacologically by ICE inhibitors in vivo.
📜 SIMILAR VOLUMES